Pfizer shot 100% effective in 12- to 15-year-olds – study

Pfizer Inc. and BioNTech SE announced on Monday the results of the phase 3 trial of their COVID-19 vaccine in adolescents between the ages of 12 and 15. The trial included 2,228 participants and showe…